Moderna Inc. said it had completed the application process for full approval of its COVID-19 vaccine in the U.S., putting the company on course to obtain the second such clearance from federal regulators. Pfizer's already done it; now it's Moderna's turn!
Photo Credit: Ian Hutchinson
Comments